Risk Prediction Model of 90-Day Mortality After Esophagectomy for Cancer

Xavier Benoît D’Journo(Aix-Marseille Université), David Boulate(Aix-Marseille Université), Alex Fourdrain(Aix-Marseille Université), Anderson Loundou(Aix-Marseille Université), Mark I. van Berge Henegouwen(University of Amsterdam), Suzanne S. Gisbertz(University of Amsterdam), J. Robert O’Neill(Addenbrooke's Hospital), Arnulf H. Hoelscher(Elisabeth-Krankenhaus Essen), Guillaume Piessen(Hôpital Claude Huriez), Jan van Lanschot(Erasmus MC), Bas P. L. Wijnhoven(Erasmus MC), Blair A. Jobe(Allegheny Health Network), Andrew Davies(National Health Service), Paul M. Schneider(Klinik Hirslanden), Manuel Pera(Hospital Del Mar), Magnus Nilsson(Karolinska University Hospital), Philippe Nafteux(KU Leuven), Yuko Kitagawa(Keio University), Christopher R. Morse(Massachusetts General Hospital), Wayne L. Hofstetter(The University of Texas MD Anderson Cancer Center), Daniela Molena(Memorial Sloan Kettering Cancer Center), Jimmy Bok Yan So(National University Hospital), Arul Immanuel(Royal Victoria Infirmary), Simon L. Parsons(National Health Service), Michael Hareskov Larsen(Odense University Hospital), James P. Dolan(Oregon Health & Science University), Stephanie G. Wood(Oregon Health & Science University), Nick Maynard(National Health Service), B. Mark Smithers(The University of Queensland), Sonia Puig(University Hospitals Birmingham NHS Foundation Trust), Simon Law(Queen Mary Hospital), Yhi Wong(Queen Mary Hospital), Andrew Kennedy(Royal Victoria Eye and Ear Hospital), Wang KangNing(Sichuan Cancer Hospital), John V. Reynolds(Trinity College Dublin), C.S. Pramesh(Tata Memorial Hospital), Mark K. Ferguson(University of Chicago), Gail Darling(Toronto General Hospital), Wolfgang Schröder(University Hospital Cologne), Marc Bludau(University Hospital Cologne), Tim Underwood(National Health Service), Richard van Hillegersberg(University Medical Center Utrecht), Andrew C. Chang(Michigan Medicine), Ivan Cecconello(Universidade de São Paulo), Ulysses Ribeiro(Universidade de São Paulo), Giovanni De Manzoni(University of Verona), Riccardo Rosati(Vita-Salute San Raffaele University), MadhanKumar Kuppusamy(Virginia Mason Medical Center), P. Thomas(Aix-Marseille Université), Donald E. Low(Virginia Mason Medical Center), International Esodata Study Group(International Breast Cancer Study Group), Geoffrey Brioude(International Breast Cancer Study Group), Delphine Trousse(International Breast Cancer Study Group), Egle Jezerskyte(International Breast Cancer Study Group), Wietse J. Eshuis(International Breast Cancer Study Group), Richard Hardwick(International Breast Cancer Study Group), Peter Safranek(International Breast Cancer Study Group), John M. Bennett(International Breast Cancer Study Group), Andrew Hindmarsh(International Breast Cancer Study Group), Vijay Sujedran(International Breast Cancer Study Group), Martin Hemmerich(International Breast Cancer Study Group), Margerite Messier(International Breast Cancer Study Group), Sebastien Degissors(International Breast Cancer Study Group), Frederiek Nuytens(International Breast Cancer Study Group), C. Mariette(International Breast Cancer Study Group), Sjoerd M. Lagarde(International Breast Cancer Study Group), Ali H. Zaidi(International Breast Cancer Study Group), Janine Zylstra(International Breast Cancer Study Group), James Gossage(International Breast Cancer Study Group), Cara Baker(International Breast Cancer Study Group), Mark Kelly(International Breast Cancer Study Group), Simone Schillinger(International Breast Cancer Study Group), Marta Gimeno(International Breast Cancer Study Group), Fredrik Klevebro(International Breast Cancer Study Group), Masaru Hayami(International Breast Cancer Study Group), Toni Lerut(International Breast Cancer Study Group), Johnny Moons(International Breast Cancer Study Group), Hirofumi Kawakubo(International Breast Cancer Study Group), Satoru Matsuda(International Breast Cancer Study Group), Yuki Hirata(International Breast Cancer Study Group), Julie M. Garrity(International Breast Cancer Study Group), Huawei Tang(International Breast Cancer Study Group), Manjit S. Bains(International Breast Cancer Study Group), Joseph Dycoco(International Breast Cancer Study Group), Kristen Busalacchi(International Breast Cancer Study Group), Rebecca Carr(International Breast Cancer Study Group), David R. Jones(International Breast Cancer Study Group), Asim Shabbir(International Breast Cancer Study Group), Michael J. Griffin(International Breast Cancer Study Group), Helen Jaretzke(International Breast Cancer Study Group), Neil T. Welch(International Breast Cancer Study Group), Ravinder Vohra(International Breast Cancer Study Group), James Catton(International Breast Cancer Study Group), J. Saunders(International Breast Cancer Study Group), Fadi Yanni(International Breast Cancer Study Group), Daniela Zanotti(International Breast Cancer Study Group), Pritam Singh(International Breast Cancer Study Group), Larsen Nicolaj(International Breast Cancer Study Group), Marcus Stilling(International Breast Cancer Study Group), Charlie Borzy(International Breast Cancer Study Group), Kayla Siemens(International Breast Cancer Study Group), John M. Findlay(International Breast Cancer Study Group), Stephen Ash(International Breast Cancer Study Group), Iain Thomson(International Breast Cancer Study Group), Andrew P. Barbour(International Breast Cancer Study Group), Janine Thomas(International Breast Cancer Study Group), John Whiting(International Breast Cancer Study Group), Jeannette Kwok(International Breast Cancer Study Group), Raymond Kennedy(International Breast Cancer Study Group), Fang Qiang(International Breast Cancer Study Group), Han YongTao(International Breast Cancer Study Group), Penh Lin(International Breast Cancer Study Group), Xiao WenGuang(International Breast Cancer Study Group), Sinéad King(International Breast Cancer Study Group), Ravinder Narayanasamy(International Breast Cancer Study Group), Apurva Ashok(International Breast Cancer Study Group), Amy Durkin-Celauro(International Breast Cancer Study Group), Catherine Staub(International Breast Cancer Study Group), Emma Small(International Breast Cancer Study Group), Christiane J. Bruns(International Breast Cancer Study Group), James Byrne(International Breast Cancer Study Group), Jamie Kelly(International Breast Cancer Study Group), Fergus Noble(International Breast Cancer Study Group), Donna Sharland(International Breast Cancer Study Group), Rachel Fraser(International Breast Cancer Study Group), Rob F. Walker(International Breast Cancer Study Group), Saqib Rahman(International Breast Cancer Study Group), Ben Grace(International Breast Cancer Study Group), Jelle P. Ruurda(International Breast Cancer Study Group), Sylvia Van der Host(International Breast Cancer Study Group), Arjen van der Veen(International Breast Cancer Study Group), Gino M. Kuiper(International Breast Cancer Study Group), Judy Miller(International Breast Cancer Study Group), Shari Barnett(International Breast Cancer Study Group), Rubens AA Sallum(International Breast Cancer Study Group), Jacopo Weindelmayer(International Breast Cancer Study Group), Carlo Alberto De Pasqual(International Breast Cancer Study Group), Paolo Parisse(International Breast Cancer Study Group), Andrea Cossu(International Breast Cancer Study Group), Francesco Puccetti(International Breast Cancer Study Group), Simonetta Massaron(International Breast Cancer Study Group), Bonnie Marston(International Breast Cancer Study Group)
JAMA Surgery
September 1, 2021
Cited by 107Open Access
Full Text

Abstract

Importance: Ninety-day mortality rates after esophagectomy are an indicator of the quality of surgical oncologic management. Accurate risk prediction based on large data sets may aid patients and surgeons in making informed decisions. Objective: To develop and validate a risk prediction model of death within 90 days after esophagectomy for cancer using the International Esodata Study Group (IESG) database, the largest existing prospective, multicenter cohort reporting standardized postoperative outcomes. Design, Setting, and Participants: In this diagnostic/prognostic study, we performed a retrospective analysis of patients from 39 institutions in 19 countries between January 1, 2015, and December 31, 2019. Patients with esophageal cancer were randomly assigned to development and validation cohorts. A scoring system that predicted death within 90 days based on logistic regression β coefficients was conducted. A final prognostic score was determined and categorized into homogeneous risk groups that predicted death within 90 days. Calibration and discrimination tests were assessed between cohorts. Exposures: Esophageal resection for cancer of the esophagus and gastroesophageal junction. Main Outcomes and Measures: All-cause postoperative 90-day mortality. Results: A total of 8403 patients (mean [SD] age, 63.6 [9.0] years; 6641 [79.0%] male) were included. The 30-day mortality rate was 2.0% (n = 164), and the 90-day mortality rate was 4.2% (n = 353). Development (n = 4172) and validation (n = 4231) cohorts were randomly assigned. The multiple logistic regression model identified 10 weighted point variables factored into the prognostic score: age, sex, body mass index, performance status, myocardial infarction, connective tissue disease, peripheral vascular disease, liver disease, neoadjuvant treatment, and hospital volume. The prognostic scores were categorized into 5 risk groups: very low risk (score, ≥1; 90-day mortality, 1.8%), low risk (score, 0; 90-day mortality, 3.0%), medium risk (score, -1 to -2; 90-day mortality, 5.8%), high risk (score, -3 to -4: 90-day mortality, 8.9%), and very high risk (score, ≤-5; 90-day mortality, 18.2%). The model was supported by nonsignificance in the Hosmer-Lemeshow test. The discrimination (area under the receiver operating characteristic curve) was 0.68 (95% CI, 0.64-0.72) in the development cohort and 0.64 (95% CI, 0.60-0.69) in the validation cohort. Conclusions and Relevance: In this study, on the basis of preoperative variables, the IESG risk prediction model allowed stratification of an individual patient's risk of death within 90 days after esophagectomy. These data suggest that this model can help in the decision-making process when esophageal cancer surgery is being considered and in informed consent.


Related Papers

No related papers found

Powered by citation graph analysis